Inactief instrument

Andere talen Capnia Inc Nasdaq

Aandelen

US14066L1052

slotkoers Nasdaq Andere beurzen
- ^USD	-

13/05	SOLENO THERAPEUTICS, INC. : Oppenheimer geeft koopadvies	ZM
10/05	SOLENO THERAPEUTICS, INC. : Baird bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Soleno Therapeutics Stands with the Prader-Willi Syndrome Community	15/05
Soleno Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	09/05
Soleno Therapeutics Prices $138 Million Stock Offering	03/05
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock	03/05
Soleno Therapeutics Announces Proposed Public Offering of Common Stock	02/05
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome	30/04
Soleno Therapeutics, Inc. Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to Natural History of Prader-Willi Syndrome	30/04
Soleno Therapeutics' Shares Jump After FDA Grants Breakthrough Designation for Prader-Willi Syndrome Treatment	29/04
Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline	29/04
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)	29/04
Soleno Therapeutics, Inc. Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome	29/04
Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director	22/04
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - April 19, 2024	22/04
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/04
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	04/04
North American Morning Briefing : Investors -2-	18/03
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/03
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	06/03
Soleno Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Capnia Inc Nasdaq

Aandelen

US14066L1052

Andere talen

Filters